Conduct a First-in-Human Study in El Salvador: A Step-by-Step Guide

Introduction

El Salvador presents a compelling landscape for MedTech, Biopharma, and Radiopharmaceutical companies eager to accelerate their clinical trials.

With regulatory approval timelines averaging just 30 to 60 days and the potential for cost savings of up to 30% per patient, El Salvador stands out as a strategic location for early feasibility trials.

Navigating local regulations and patient recruitment can be daunting for researchers, yet overcoming these hurdles is essential for success.

To harness the potential of this market, researchers must strategically leverage the advantages of this promising market while ensuring compliance and operational efficiency.

Understand the Regulatory Landscape for FIH Trials in El Salvador

Navigating the regulatory landscape for the first-in-human study El Salvador presents both challenges and opportunities for clinical researchers. To conduct a successful trial, understanding the framework governed by the Superintendencia de Regulación Sanitaria (SRS) and the National Directorate of Medicines (DNM) is crucial. The approval process typically takes between 30 to 60 days, making the first-in-human study El Salvador an attractive location for trials, especially when compared to the longer timelines often seen in the US and EU. Here are the key steps:

1. Identify Regulatory Authorities: Recognize the distinct roles of the SRS, which oversees overall regulation, and the DNM, which evaluates research design and safety. Understanding these authorities is crucial for navigating the regulatory pathways effectively.
2. Review Submission Requirements: Ensure familiarity with necessary documentation, including the clinical study protocol, Investigator’s Brochure, and informed consent forms, all of which must comply with ICH-GCP standards. El Salvador accepts foreign certificates like FDA or CE to support certain submissions, but compliance with local SRS requirements is mandatory.
3. Understand Approval Timelines: Anticipate a review period of approximately 30 days for ethical approval. All documents must be submitted in Spanish to facilitate the review process, which can significantly expedite timelines compared to other regions. Additionally, trials can typically start within 6-8 weeks, allowing for faster delivery of FDA-bridgeable data.
4. Prepare for Inspections: Prepare yourself for evaluations by oversight authorities, as they play a crucial role in ensuring compliance with local regulations.
5. Leverage the SRS-CNEIS-ES Platform: Utilize the SRS-CNEIS-ES platform for streamlined submissions, which includes registration, document upload, real-time tracking of approval status, and secure messaging for effective communication with oversight bodies. This integrated digital platform reduces administrative burdens and enhances submission management.
6. Monitor Submission Progress: Regularly check the status of submissions and respond promptly to any requests for additional information from the SRS to maintain review timelines.
7. Engage Local Expertise: Collaborate with local healthcare providers and regulatory consultants to enhance patient recruitment and ensure compliance with local regulations, thereby improving the chances of successful study execution. Additionally, ensure that the clinical study protocol outlines the study’s objectives, methodology, and statistical analysis plan to meet ICH-GCP standards. By embracing local expertise and understanding the regulatory framework, researchers can unlock the potential for faster, more efficient trials in this promising market. Conducting studies in Latin America can also result in cost reductions of about 30% lower per-patient expenses compared to US/EU benchmarks.

Prepare Essential Documentation and Obtain Ethical Approvals

Navigating the compliance landscape in El Salvador can be daunting, but with the right preparation, you can ensure your clinical trial meets all necessary ethical standards. To achieve this, follow these detailed steps:

1. Draft the Clinical Study Protocol: Clearly outline the study’s objectives, methodology, and statistical analysis plan. Compliance with ICH-GCP guidelines is essential, and thorough safety information must be included to adhere to regulatory requirements.
2. Create the Investigator’s Brochure: This document should provide comprehensive information about the investigational product, covering pharmacology, toxicology, and any previous clinical data. Such details are crucial for the ethics committee’s review.
3. Prepare Informed Consent Forms: Develop clear and concise informed consent forms that meet ethical standards. These forms must ensure that participants fully understand the study’s purpose, risks, and benefits, which is critical for ethical compliance.
4. Submit for Ethical Review: Submit your documentation to an independent ethics committee for review. In El Salvador, expect a review period of approximately 30 days. It’s vital to submit all documents in Spanish to facilitate the review process and avoid delays.
5. Address Feedback: Be ready to respond to any feedback or requests for modifications from the ethics committee. Swiftly addressing these is essential for obtaining approval and moving forward with your study.

By adhering to these steps, you not only comply with regulations but also enhance the credibility and success of your clinical study in a competitive market.

Execute the Trial: Manage Recruitment and Site Operations

Effective management of recruitment and site operations is not just beneficial; it’s essential for the success of your clinical study. What strategies can you implement to optimize these processes?

1. Develop a Targeted Recruitment Strategy: Collaborate with local healthcare providers to identify potential participants. Leverage social media platforms and community outreach initiatives to raise awareness about the trial, ensuring that messaging resonates with diverse populations.
2. Select pre-qualified clinical trial sites that have demonstrated expertise in the first-in-human study El Salvador initiatives. Ensure these sites are equipped with the necessary infrastructure and trained personnel to facilitate smooth operations and participant engagement.
3. Train Site Staff Thoroughly: Conduct comprehensive training sessions for site personnel to ensure they are well-versed in the protocol, ethical considerations, and data collection procedures. This training is essential for maintaining compliance with ICH-GCP standards and local legal requirements.
4. Monitor Recruitment Progress Regularly: Continuously assess recruitment metrics to identify challenges and adapt strategies as necessary. Consider implementing incentives for participation to enhance enrollment rates, particularly in underrepresented communities.
5. Ensure Strict Compliance with Protocol: Closely monitor site operations to guarantee adherence to the study protocol and regulatory requirements. Conduct regular site visits and audits to maintain information integrity and ensure participant safety, which is crucial in the first-in-human study El Salvador.

Navigating these complexities can significantly enhance your study’s success and impact in the field of clinical research.

Manage Data Collection and Analysis for Regulatory Submission

In the realm of clinical research, the meticulous collection and analysis of data is not just a step; it’s a cornerstone of successful outcomes. After carrying out the trial, the subsequent step is to oversee the collection and analysis of information effectively. Follow these guidelines:

1. Leverage Collection Tools: Utilize electronic capture (EDC) systems to optimize data collection and guarantee real-time entry. This reduces errors and enhances information integrity.
2. Establish Management Protocols: Develop clear protocols for handling, storage, and analysis. Ensure that all information is traceable and compliant with ICH-GCP standards.
3. Conduct Regular Monitoring of Information: Oversee information collection processes consistently to detect discrepancies or issues early. Implement corrective measures as necessary to uphold quality of information.
4. Examine Information for Submission: Upon completion of data collection, execute a comprehensive analysis to ensure readiness for compliance submission. Ensure that the analysis aligns with the statistical methods outlined in the research protocol.
5. Prepare Regulatory Submission Documents: Compile all necessary documents, including the final study report, data analysis results, and any additional supporting materials required by the regulatory authorities for submission. Neglecting these steps could jeopardize the integrity of your research and the trust of regulatory bodies.

Conclusion

El Salvador’s regulatory landscape offers a compelling opportunity for clinical researchers aiming to conduct first-in-human studies, allowing them to navigate the approval process efficiently, typically within 30 to 60 days. This rapid timeline, combined with the ability to initiate trials within 6-8 weeks, positions El Salvador as a strategic advantage for early-stage clinical trials.

To ensure success, researchers must prepare thoroughly, from drafting essential documentation to engaging local expertise for patient recruitment. Compliance with ICH-GCP standards and local regulations is crucial for the success of clinical trials, as these factors significantly influence outcomes. Moreover, leveraging tools such as the SRS-CNEIS-ES platform can enhance submission management and streamline communication with regulatory authorities, further expediting the process.

In conclusion, conducting first-in-human studies in El Salvador not only promises faster timelines and reduced costs-approximately 30% lower per-patient expenses compared to US/EU benchmarks-but also opens doors to a diverse patient population and bilingual site capabilities. The potential for groundbreaking advancements in healthcare hinges on the strategic choices made today in clinical research. Engaging with a specialized contract research organization like bioaccess® can ensure that researchers are well-equipped to navigate this promising landscape effectively.

Frequently Asked Questions

What regulatory authorities govern first-in-human trials in El Salvador?

The regulatory landscape for first-in-human trials in El Salvador is governed by the Superintendencia de Regulación Sanitaria (SRS) and the National Directorate of Medicines (DNM). The SRS oversees overall regulation, while the DNM evaluates research design and safety.

What is the typical approval timeline for clinical trials in El Salvador?

The approval process for clinical trials in El Salvador typically takes between 30 to 60 days, with ethical approval usually taking around 30 days. Trials can often start within 6-8 weeks.

What are the submission requirements for conducting trials in El Salvador?

Submission requirements include necessary documentation such as the clinical study protocol, Investigator’s Brochure, and informed consent forms, all of which must comply with ICH-GCP standards. Documents must be submitted in Spanish, and while foreign certificates like FDA or CE are accepted, compliance with local SRS requirements is mandatory.

How can researchers streamline the submission process in El Salvador?

Researchers can utilize the SRS-CNEIS-ES platform for streamlined submissions, which allows for registration, document upload, real-time tracking of approval status, and secure messaging with oversight bodies.

What should researchers do to prepare for inspections by regulatory authorities?

Researchers should prepare for evaluations by oversight authorities, ensuring compliance with local regulations and being ready to provide any necessary documentation during inspections.

How can local expertise enhance the success of clinical trials in El Salvador?

Engaging local healthcare providers and regulatory consultants can improve patient recruitment and ensure compliance with local regulations, thereby enhancing the chances of successful study execution.

What are the potential cost savings of conducting trials in El Salvador compared to the US/EU?

Conducting studies in El Salvador can result in cost reductions of approximately 30% lower per-patient expenses compared to US/EU benchmarks, with costs ranging from $15,000 to $35,000 compared to $40,000 to $75,000 in the US/EU.

List of Sources

1. Understand the Regulatory Landscape for FIH Trials in El Salvador
   • User Guide for Clinical Trial Submissions on the SRS–CNEIS-ES Platform: El Salvador 2025 (https://regdesk.co/blog/user-guide-for-clinical-trial-submissions-on-the-srs-cneis-es-platform-el-salvador-2025)
   • How to Conduct a First in Human Trial in El Salvador: A Step-by-Step Guide | bioaccess® (https://bioaccessla.com/blog/how-to-conduct-a-first-in-human-trial-in-el-salvador-a-step-by-step-guide)
   • Latin America the ‘Hidden Gem’ for First-in-Human Medical Device Trials (https://clinicalresearchnewsonline.com/news/2025/08/14/latin-america-the-hidden-gem-for-first-in-human-medical-device-trials)
2. Prepare Essential Documentation and Obtain Ethical Approvals
   • Clinical Trial Protocol Development Best Practices for Success (https://comac-medical.com/clinical-trial-protocol-development-best-practices-for-success)
   • Writing a Clinical Trial Protocol: Expert Tips (https://kolabtree.com/blog/how-to-write-a-clinical-trial-protocol/amp)
   • Drafting a clinical study protocol – An overview (https://capgemini.com/insights/research-library/drafting-a-clinical-study-protocol)
   • Design a Clinical Research Protocol: Influence of Real-World Setting – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC10454664)
3. Execute the Trial: Manage Recruitment and Site Operations
   • Clinical studies: the challenge of patient recruitment (https://servier.com/en/newsroom/clinical-studies-patient-recruitment)
   • 25+ useful clinical trial recruitment statistics for better results (https://antidote.me/blog/25-useful-clinical-trial-recruitment-statistics-for-better-results)
   • Enrollment in Clinical Trials: Statistics and Patient Recruitment Strategies | Power (https://withpower.com/guides/enrollment-in-clinical-trials-statistics-and-patient-recruitment-strategies)
   • Why participant recruitment remains the biggest challenge in clinical trials (https://linkedin.com/pulse/why-participant-recruitment-remains-biggest-challenge-arb0e)
4. Manage Data Collection and Analysis for Regulatory Submission
   • Electronic Data Capture (EDC) Systems Explained (https://ccrps.org/clinical-research-blog/electronic-data-capture-edc-systems)
   • Enough, already: the problem with clinical trial data collection (https://statnews.com/2026/06/22/clinical-trial-data-how-much-is-too-much)
   • Clinical Trials Data Management and Analysis (https://studypages.com/blog/clinical-trials-data-management-and-analysis)
   • The Ultimate Guide to Electronic Data Capture for Clinical Trials (https://quanticate.com/blog/electronic-data-capture-systems-in-clinical-trials?hs_amp=true)
   • 8 key benefits of electronic data capture for clinical trials | Viedoc (https://viedoc.com/blog/key-benefits-electronic-data-capture-clinical-trials)